BioVersys AG is a privately held Swiss pharmaceutical company focusing on R&D of small molecules acting on novel bacterial targets with applications in Anti-Microbial Resistance (AMR) and targeted microbiome modulation.

Cooperation possibilities

Partnering options for the co-development of TRIC molecules restoring the activity of approved antibiotics against severe hospital acquired bacterial infections. TRIC molecules have the ability to switch-off bacterial resistance.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in